A common approach uses 0.25mg in the morning and 0.25mg in the evening, maintaining more consistent tissue levels throughout the day
Users report feeling less exhausted during the initial weeks of therapy when B12 is included compared to anecdotal reports from those using tirzepatide alone
Aptamers have different advantages over antibodies, including much smaller size (making them more appropriate to penetrate solid tumors), less immunogenicity (reducing resistance to treatment), the capability to manipulate their length and physicochemical properties (making them possible to change the half-life, pH sensitivity, flexibility, and conjugation capacity), fast and simple production procedure, negligible inter-batch variation, and better temperature resistance [210,211,212,213,214]
CagriSema is a new medication for overweight and obesity that consists of two active ingredients: semaglutide and cagrilintide